We're building the systematic infrastructure that makes field intelligence finally work at scale - transforming how Fortune 500 medical device companies make multi-million dollar product decisions.
Transform medical device product development from intuition-driven guesswork into systematic, data-informed decision making by making field intelligence finally work at scale.
Become the industry-standard infrastructure for field intelligence in medical device innovation, making it unthinkable to launch products without systematic validation from the field.
Medical device product leaders face a fundamental field intelligence gap. They make multi-million dollar decisions about instrumentation sets, product launches, and R&D investments without knowing what's actually happening in operating rooms.
The manual reality? Product leaders texting individual reps at 6am hoping for responses. Building five-year roadmaps based on relationships with the ten reps who actually call back. Literally standing in ORs to observe what's happening because there's no other way to get the data.
The cost? $8M+ per month for delayed product launches when critical instruments are missed. Million-dollar post-launch redesigns when assumptions prove wrong. Bloated instrumentation sets carrying items that sit unused in expensive inventory.
Field intelligence has always existed in medical device companies. It's just never worked at scale. OpSync changes that.
Building field intelligence infrastructure alongside product leaders from Fortune 500 medical device companies.
Selected as MDOC 2025 finalist, judged by executives from Medtronic, Smith & Nephew, and other medical device industry leaders. The Medical Device Operations Challenge recognizes innovation in medical device operations and supply chain.
Backed by Alchemist Accelerator, Silicon Valley's leading enterprise startup accelerator. Receiving mentorship from industry leaders, seasoned founders, and enterprise go-to-market experts.
Building OpSync alongside product leaders from Medtronic Cranial & Spinal Technologies and other Fortune 500 medical device companies. Our Customer Advisory Board provides direct validation and partnership as we define the field intelligence category.
Defining the field intelligence category for MedTech through systematic problem validation, customer partnerships, and building infrastructure that Fortune 500 companies depend on for product decisions.
